AKTX

Akari Therapeutics plc ADS (AKTX)

About Akari Therapeutics plc ADS (AKTX)

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.

Details

Daily high

$1.34

Daily low

$1.22

Price at open

$1.22

52 Week High

$4.40

52 Week Low

$0.85

Market cap

35.1M

Dividend yield

0.00%

Volume

4,476

Avg. volume

33,545

P/E ratio

-.19

Akari Therapeutics plc ADS News

Details

Daily high

$1.34

Daily low

$1.22

Price at open

$1.22

52 Week High

$4.40

52 Week Low

$0.85

Market cap

35.1M

Dividend yield

0.00%

Volume

4,476

Avg. volume

33,545

P/E ratio

-.19